The Paladin Study of the Fluocinolone Implant Treating Diabetic Macular Edema
03/10/22 • 16 min
The fluocinolone implant at 3 years is a useful modality for treating diabetic macular edema. Discussion with Dr. Michael Singer, Adjunct Professor University of Texas at San Antonio.
The fluocinolone implant at 3 years is a useful modality for treating diabetic macular edema. Discussion with Dr. Michael Singer, Adjunct Professor University of Texas at San Antonio.
Previous Episode
A Tyrosine Kinase Inhibitor that Successfully Treats nAMD
We discuss the DAVIO trial of EYP-1901 with Dr. Jay S. Duker, Chief Operating Officer of Eyepoint Pharmaceuticals.
Next Episode
The Altissimo Study using a TKI for nAMD
We review the results of the phase I Graybug study Altissimo using sustained release tyrosinase kinase inhibitor for long term treatment of neovascular AMD with Dr. Veeral Sheth, Chicago, Illinois, Assistant Clinical Professor University of Illinois at Chicago.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/retina-synthesis-352057/the-paladin-study-of-the-fluocinolone-implant-treating-diabetic-macula-50910546"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to the paladin study of the fluocinolone implant treating diabetic macular edema on goodpods" style="width: 225px" /> </a>
Copy